Reuters logo
BRIEF-Fosun International updates on acquisition of controlling interest in Gland Pharma
April 24, 2017 / 11:14 AM / 5 months ago

BRIEF-Fosun International updates on acquisition of controlling interest in Gland Pharma

April 24 (Reuters) - Fosun International Ltd :

* Progress on acquisition of controlling interest in Gland Pharma Limited

* Termination date was extended to 27 april 2017 in accordance with share purchase agreement

* Fosun Pharma, buyer, KKR, founder shareholders & target co entered into amendment agreement to extend termination date Source text : (bit.ly/2p8RjWr) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below